SCHEMBL6036896

SCHEMBL6036896

ClC1=CC2=NC1C(c1ccncc1)c1ccc([nH]1)/C(c1ccncc1)=C1/C=CC(N1)/C(c1ccncc1)=c1/cc/c([nH]1)=C/2c1ccncc1.[Mn]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL859361 0.76 GCGR (0.33) —
SCHEMBL10017406 0.73 — —
SCHEMBL3459766 0.71 GCGR (0.32) —
SCHEMBL7705568 0.71 TOP1 (0.34) —
SCHEMBL14076169 0.63 — —
SCHEMBL5384591 0.62 CYP3A4 (0.34) —
SCHEMBL17366427 0.55 — —
SCHEMBL17366426 0.46 GCGR (0.41) —
SCHEMBL13977794 0.45 MKNK1 (0.55) —
SCHEMBL13977458 0.44 GCGR (0.74) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1721149-A1 ANALYTE SENSOR, AND ASSOCIATED SYSTEM AND METHOD EMPLOYING A CATALYTIC AGENT Therasense, Inc. (US) 2006-11-15 — — EP claimed
WO-2005078424-A1 ANALYTE SENSOR, AND ASSOCIATED SYSTEM AND METHOD EMPLOYING A CATALYTIC AGENT THERASENSE INC. (US) 2005-08-25 — — WO claimed
Send feedback